Biotecan SARS-Cov-2 nucleic acid detection—provide a protective barrier for elderly people24 June 2020
Recently, Biotecan screened the staffs from more than 70 community pension service institutions in Pudong New Area, Shanghai for SARS-Cov-2 by nucleic acid detection. This task was commissioned by the Shanghai Civil Affairs Bureau.
The scene of sampling for SARS-Cov-2 nucleic acid detection in the community pension service institutions
Our firm’s staffs provided on-site sampling service for the staffs of different community pension service institutions which were distributed in various regions of Pudong New Area. In some remote places (Lingang new town or Laogang town, for instance), staffs have to drive up to two hours to get there. To complete the task efficiently, our staffs made full preparation for the work in the early stage, such as inputting the identity information in advance so as to ensure the sampling process fast and accurate. Within one week, we completed the sampling work of more than 70 community pension service institutions.
Furthermore, in order to issue the test report in time, our experimenters worked overtime. And all the test reported within 12-24 hours.
The scene of sampling and detection for SARS-Cov-2 nucleic acid
Biotecan has undertaken novel Coronavirus screening work appointed by various enterprises and institutions, especially for those who are ready to return to work or school, those who were back to Shanghai from high risk area and those foreign arrivals. We hope to contribute our scientific and technological strength to the safe resumption of work and schools, businesses and markets, and the prevention of the spread of the epidemic.